October 3, 2016—To clamp down on rising drug prices, Congress should protect the 340B drug discount program – a rare public policy initiative that helps healthcare providers and their patients, the leader of a group of more than 1,200 safety-net hospitals writes in a new op-ed for Yahoo Finance.
You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register. Already registered? Click here to login. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)